NCT04032522View on ClinicalTrials.gov

Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE)

CompletedOBSERVATIONAL
Enrollment

6,602

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

January 1, 2023

Study Completion Date

January 1, 2023

Conditions
HIV, Neonatal HIV Early-Infant-Diagnosis (EID), Point-of-Care Testing (PoC)
Interventions
OTHER

point-of care (PoC) neonatal HIV early infant diagnosis (EID)

clinical impact of a PoC-EID for infants and neonates at birth and week 4-8 weeks, linked with nurse-supported immediate ART initiation in HIV-infected neonates, versus standard-of-care (SoC)

Trial Locations (2)

Unknown

Centro de Investigacao Operacional da Beira (CIOB), Beira

Mbeya Medical Research Centre, Mbeya

All Listed Sponsors
collaborator

Instituto Nacional de Saúde, Mozambique

OTHER_GOV

collaborator

NIMR- Mbeya Medical Research Centre (MMRC), Mbeya, Tanzania

UNKNOWN

collaborator

University of Lisbon Instituto Universitário Egas Moniz (IUEM) Lisbon, Portugal

UNKNOWN

collaborator

Clinton Health Access Initiative Inc.

OTHER

lead

Michael Hoelscher

OTHER

NCT04032522 - Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE) | Biotech Hunter | Biotech Hunter